Novel method for interrogating receiver operating characteristic curves for prognostic tests
Disease prevalence is rarely explicitly considered in the early stages of the development of novel prognostic tests. Rather, researchers use…
Read More
Prof. Louise Kenny, Founding Director, wins Women Mean Business in Technology Award
Metabolomic Diagnostics wins Women Mean Business Woman In Technology Award WMB held its 11th annual Women Mean Business Conference &…
Read More
Robin Tuytten serves on Advisory Board of HUPO 2017
Robin Tuytten, Metabolomic Diagnostics VP Research and Development serves on the Advisory Board of HUPO 2017 the 16th Annual World…
Read More
Metabolomic Diagnostics: Adding to our highly skilled team
Metabolomic Diagnostics are delighted to welcome Dr. Anna Suhr to the team in Cork, Ireland. Dr. Anna Suhr is a…
Read More
Robin Tuytten speaks at Bravo and Assaymap Bravo Interest Group
Robin Tuytten, Metabolomic Diagnostics VP Research and Development spoke at the recent Bravo and Assaymap Bravo Interest Group meeting September…
Read More
Metabolomic Diagnostics secures additional $2 million in venture funding
Metabolomic Diagnostics, has secured an additional €1.6 million in from investors to help complete PrePsia™, its new screening test for…
Read More